EUVIMEDEUVIMED entdecken
Übersichtsarbeit

How to treat undifferentiated arthritis today or tomorrow? A consideration of treatment recommendations in light of current evidence

Annette H M van der Helm-van Mil, Daniel Aletaha

Annals of the Rheumatic Diseases · 2025-04 · 84 (4) · 521-528

DOI: 10.1016/j.ard.2025.01.036 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of the Rheumatic Diseases, 2025-04. Verfasst von Annette H M van der Helm-van Mil und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: AvdHelm@lumc.nl. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with undifferentiated arthritis (UA) have clinically apparent inflammatory arthritis but no evident diagnosis or classification. Considering UA as a definition 'per exclusionem' implies that the population designated by this term is affected by changes in the way other diseases, eg, rheumatoid arthritis (RA), are classified or diagnosed. Current treatment recommendations for UA are largely similar to recommendations for RA. The recommendations are based on the idea that UA is an early stage of RA and on literature generated in the 2000s before the development of the 2010 classification criteria for RA. However, conventional UA (so-called '1987-UA') is presumably different than contemporary UA ('2010-UA'). Strikingly, there are no randomised placebo-controlled trials done on '2010-UA,' and this poses questions on whether the recommendations for UA are still valid. In this absence, we assume that treatment recommendations from '1987-UA' can be extrapolated to '2010-UA' if (1) essential patient characteristics are the same, (2) long-term outcomes are similar, (3) prognostic factors are largely the same, and (4) there are indications from research other than placebo-controlled randomized clinical trials (RCTs) that disease modifying antirheumatic drug (DMARD) treatment in 2010-UA is effective. We evaluate these requirements one by one based on the literature on 2010-UA. This reveals that 2010-UA is milder in initial presentation and disease outcomes than 1987-UA. Today's UA population is >95% anticitrullinated protein antibody-negative, presents with mono- or oligoarthritis, frequently achieves spontaneous remission, and rarely progresses to RA. We suggest that 2010-UA is a distinct patient group within the early arthritis spectrum, requiring additional research, after which recommendations may need to be updated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsArthritisHumansPractice Guidelines as TopicArthritis, RheumatoidEvidence-Based Medicine

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: AvdHelm@lumc.nl.
  • Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Zitieren

APA

van der Helm-van Mil, A. H. M., & Aletaha, D. (2025). How to treat undifferentiated arthritis today or tomorrow? A consideration of treatment recommendations in light of current evidence. Annals of the Rheumatic Diseases, 84(4), 521-528. https://doi.org/10.1016/j.ard.2025.01.036

Vancouver

van der Helm-van Mil AHM, Aletaha D. How to treat undifferentiated arthritis today or tomorrow? A consideration of treatment recommendations in light of current evidence. Annals of the Rheumatic Diseases. 2025;84(4):521-528. doi:10.1016/j.ard.2025.01.036

BibTeX
@article{vanderHelmvanMil2025,
  author = {van der Helm-van Mil, Annette H M and Aletaha, Daniel},
  title = {How to treat undifferentiated arthritis today or tomorrow? A consideration of treatment recommendations in light of current evidence},
  journal = {Annals of the Rheumatic Diseases},
  year = {2025},
  volume = {84},
  number = {4},
  pages = {521--528},
  doi = {10.1016/j.ard.2025.01.036}
}
Kostenlos starten →